Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides ... via an autoinjector. The FDA approval was based on data from ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) mechanisms to tackle the root causes of obesity. It ...
The Food and Drug Administration approved Eli Lilly ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...
Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults with familial ... the Tryngolza brand name as an adjunct to diet to reduce triglycerides in adults with FCS ...
The Food and Drug Administration (FDA) gave the green light ... in combination with a reduced-calorie diet and increased physical activity. “Today’s approval marks the first drug treatment ...
Red Dye No. 3, also known as erythrosine, is a synthetic food dye that gives foods and drinks a bright red color. It is also ...
Artificial sweeteners are everywhere, even in foods you may not consider sweet. Here are five expert tips on how to cut or reduce fake sugars from your diet.
The U.S. Food and Drug Administration (FDA) has granted approval to crinecerfont, an innovative oral drug designed to treat classic congenital adrenal hyperplasia (CAH) in patients aged four years ...
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound ... The drug is designed to be used alongside a reduced-calorie diet and increased physical activity, offering ...